The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...

In another milestone, Eli Lilly's weight-loss medication, Zepbound, received FDA approval, marking it as the first drug to specifically tackle moderate to severe obstructive sleep apnea in obese ...

Texas says the state committee that reviews pregnancy-related deaths will not look at cases from 2022 and 2023, the first two ...

Zepbound, a popular weight loss drug, has become the first FDA-approved prescription medication to treat obstructive sleep ...

And here’s what else you need to know to Start Your Week Smart . Your day is busy. 5 Things is your one-stop shop for the ...

"Zepbound is the first medication that significantly improves moderate-to-severe OSA and aids in long-term weight loss in adults with obesity." ...

Unfortunately, it’s necessary to commence a wind down process immediately.” Jamie Foxx and Cameron Diaz attempted to put an ...

Soccer star Trinity Rodman was less than pleased with her NBA legend father’s apology for being absent from her life.

The FDA approved Eli Lilly's Zepbound as the first drug for obesity-linked moderate-to-severe sleep apnea, potentially transforming treatment options for 80 million Americans.

The FDA said studies have shown that by aiding weight loss, Zepbound improves sleep apnea symptoms in some patients.